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Purpose: This report ascertained factors responsible for failure of foot salvage in patients 
with end-stage renal disease (ESRD) after undergoing infrainguinal bypass for critical 
ischemia. 
Methods: A retrospective r view of 69 distal arterial reconstructions performed in 53 
patients with ESRD (hemodialysis [n = 37], kidney transplantation [n = 10], peritoneal 
dialysis [n = 6]) for foot gangrene (n = 28), nonhealing ulcer (n = 25), or ischemic rest 
pain (n = 16) was conducted. Endpoints of surgical morbirty, limb loss, and graft 
patency were correlated with extent of preoperative tissue loss and presence of diabetes 
mellims. 
Results: The 30-day operative mortality rate was 10%, and the patient survival rate at 2 
years was 38%. The primary graft patency rate was 96% at 30 days, 72% at 1 year, and 
68% at 2 years. Eleven of 22 foot amputations performed uring the mean follow-up 
period of 14 months (range 3 to 96 months) occurred within 2 months of revasculariza- 
tion. Mechanisms responsible for limb loss included graft failure (n -- 9), foot ischemia 
despite a patent bypass (n = 8), and uncontrolled infection (n = 5). Overall, 59% of 
amputations were performed in limbs with a patent bypass to popliteal or tibial arteries. 
Healing of forefoot amputations was prolonged, but all limb loss beyond 9 months of 
revascularization was due to graft failure. The limb salvage rate at 1 year decreased 
(p = 0.13) from 74% to 51% in patients admitted with gangrene. Only two of seven 
patients admitted with forefoot gangrene xperienced foot salvage. 
Conclusion: Failure of foot salvage in patients with ESRD and critical ischemia was due to 
wound healing problems rather than graf* thrombosis. Earlier referral for revasculariza- 
tion, before development of extensive tissue ischemia nd infection, is recommended. 
Primary amputation should be considered in patients admitted with forefoot gangrene, 
particttlarly if it is complicated by infection. (J VASC SURG 1995;22:280-6.) 
Lower limb revascularization has been advocated 
to patients with end-stage renal disease (ESRD) 
when critical ischemia develops to improve quality of 
life. Surgical revascularization can be arduous be- 
cause of comorbid heart and pulmonary disease, as 
weil as anticipated ifficulties with wound healing 
and infection resulting from uremia, malnutrition, 
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diabetes mellims, and long-term immunosuppres- 
sion. A role for primary amputation has been 
suggested, but the patient cohort in whom the 
expense and manpower of revascularization can be 
avoided has not been clearly defined. With modern 
day techniques of lower limb revascularization a d 
free muscle flap tissue transfer, even patients with 
forefoot or hindfoot gangrene are often deemed 
suitable candidates for limb salvage surgery if a 
suitable nmoff  artery and venous conduit are avail- 
able. Unfortunately, in the patient population with 
ESRD and foot ischemia, these advancements in 
distal artery bypass grafting and tissue healing have 
not uniformly resulted in foot salvage, particularly in 
patients with long-standing insulin-dependent diabe- 
tes mellitus. Several authors have reported clinical 
failure with limb amputation despite a functioning 
bypass graft. I-7 
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Table I. Patient demographics 
Sex 
Male 27 
Female 26 
Age (yr.) 
Mean 59 
Range 32-84 
Risk factors 
Diabetes 43 (81%) 
Hypertension 41 (77%) 
Coronary artery disease 20 (38%) 
Cigarette smoking 12 (22%) 
Stroke 8 (15%) 
Heart failure 8 (15%) 
Prior myocardial infarct 4 (7.5%) 
We have used similar criteria for revascularization 
in patients with ESRD as for other patients with 
critical ischemia from atherosclerosis obliterans be- 
cause of a perceived similar outcome, particularly 
regarding early graft patency and surgical morbidity. 
Limb salvage in the patient population with ESRD 
offen requires more than successful bypass grafting; 
control of infection and achieving adequate tissue 
perfusion for healing are also crucial for success. In 
this review, we have cxamined the factors responsible 
for limb loss in patients with ESRD diagnosed with 
critical ower limb ischemia who undelxvent infrain- 
guinal bypass grafting. 
CLINICAL POPULATION AND METHODS 
OF STUDY 
The records of 53 patients with ESRD who 
underwent 69 infrainguinal bypass grafts from No- 
vember 1983 to December 1994 for critical limb 
ischemia by staff of the Virginia Vascular Associates 
(M.H.G., Eastern Virginia Medical School, [n = 
56]) or the Division of Vascular Surgery at the 
Universiry ofSouth Florida (D.F.B., [n = 13]) were 
reviewed. The two primary surgeons (M.H.G. and 
D.F.B.) in most of the procedures had completed 
surgical training together, therefore approaches to 
revascularization was similar. The patient popula- 
tions with ESRD were alike becanse the institutions 
involved in the study were tertiary care centers. 
Patients receiving long-term hemodialysis (n = 37), 
peritoneal dialysis (n = 6), or a functioning kidney 
transplant (n = 10) were included. The group was 
composed of 27 men and 26 women with a mean age 
of 59 years (Table I). Eighty-one percent of patients 
had diabetes meHitus. Critical foot ischemia was the 
indication for revascularization in the 69 limbs and 
included nonhealing ulcer (n = 25), digit gangrene 
(n = 21), ischemic rest pain (n = 16), and forefoot 
Table II. Distribution of distal anastomosis 
for 69 infrainguinal rterial bypasses 
Sites of distal anastomosis No. 
Popliteal artery 
Above-knee 7 
Below-knee 12 
Anterior tibial artery 20 
Posterior tibial artery 11 
Peroneal artery 6 
Pedal arteries 13 
gangrene (n = 7). Revascularizations pcrformed 
solely for intermittent claudication were excluded. 
Primary amputation was performed in those patients 
whose preoperative angiograms howed extensive 
distal atherosclerotic disease not amenable to bypass 
(isolated popliteal segments were considered ame- 
nable to bypass). In general, patients had measured 
ankle/brachial pressure indexes (A_BI) less than 0.5 
and toe pressures less than 40 mm Hg or, when 
incompressible tibial arteries were detected, abseht 
pulsatile arterial flow in the plantar or digital arteries. 
The type of bypass grafting included in situ 
saphenous vein (n = 36), reversed saphenous vein 
(n = 26), polytetrafluoroethylene bypass (n = 5), 
and homografts in two instances. Most (65%) of the 
bypasses originated from the common femoral ar- 
tery, but the popliteal artery was deemed a suitable 
inflow artery in 24% of cases. Table II 1ists the site of 
distal anastomosis for the 69 infrainguinal bypass 
grafts. Infrageniculate or pedal arteries were the graft 
outflow in 72% of the procedures. 
Outcome analysis. Survival, limb salvage, and 
graft patency were analyzed by life-table methods. A
Mantel-Haenszel test was performed to compare 
procedure outcomes. Graft patency was assessed by 
duplex scanning at 3-month intervals during the first 
postoperative y ar and at 6-month intervals thereaf- 
ter. Any bypass that ocduded or required a subse- 
quent procedure (thrombectomy, thrombolysis, or 
graft revision) to restore or maintain functional 
patency resulted in loss ofprimary patency. Salvage of 
the foot was defined as relief of rest pain or healing 
of ischemia lesions or amputations at the digit or 
forefoot level. Outcome (death, graft patency, or foot 
amputation) was correlated with the presence of 
preoperative gangrene, diabetes mellitus, and type of 
revascularization. Failure of foot salvage via the 
mechanisms of graft thrombosis, persistent foot 
ischemia, and infection with a patent bypass or 
uncontrolled infection were tabulated for each post- 
operative interval. 
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Table III. Cause of limb loss during postoperative follow-up 
Bypass graft status 
Postoperative interval Reason for foot 
(mo.) No. of amputations Patent Thrombosed amputations 
0-1 6 5 1 Foot ischemia-3 
Infection-2 
Graft failure- 1 
1-2 5 5 0 Foot ischemia-4 
Infection-1 
2-12 8 3 5 Foot ischemia- 1 
Infection-2 
Graf* failure-5 
12-24 2 0 2 Graft failure-2 
> 24 1 0 1 Graft failure-1 
Table IV. Cumulative limb salvage rates 
Interval No. of limbs No. of limbs No. Interval Cumulative salvage 
(mo.) at risk lost withdrawn limb loss (%) SE (%) 
0-1 69 6 8 .91 100 0 
1-3 55 6 3 .89 91 3.7 
3-6 46 3 8 .93 81 5.2 
6-12 35 4 8 .87 75 6.3 
12-18 23 1 4 .95 65 8.0 
18-24 17 1 5 .93 62 9.3 
24-30 11 0 1 1.00 57 11.3 
RESULTS 
The 30-day operative mortality rate was 10% 
(seven pafients), with three deaths the result ofmyo- 
cardial infarcfion. The patient survival rate at I and 2 
years was 58% and 38%, respectively. Postoperative 
wound complications developed in 20 (29%) limbs 
and included ehiscence asa result ofdermal necrosis 
(n = 10), infection (n = 6), hematoma (n = 3), 
and seroma (n = 1). Two wound infections involved 
the bypass graft and required ligation followed by 
limb amputation. Persistent foot ischemia (nonheal- 
ing ulcer, extension of gangrene, or unresolved rest 
pain) and uncontrolled infection (progressive infec- 
tion extending to deep tissues/joints or infection of 
the incision requiring raft ligation) despite apatent 
bypass graft were major causes oflimb loss within the 
first 2 months of revascularization (Table III). Persis- 
tent foot ischemia was manifest in eight patients, all 
of whom had diabetes, as progressive tissue gan- 
grene, unresolved rest pain, or the nonhealing and 
subscquent breakdown of a forefoot amputation site. 
Sites of distal anastomosis in the patients with foot 
ischemia despite apatent bypass were tibial (n = 6), 
pedal (n = 1), and below-knee popliteal (n = 1) ar- 
teries. The preoperative angiographic reports in three 
of these patients revealed an incomplete foot arch, 
whereas the bypass to the popliteal artery was to an 
isolated segment. Postoperative noninvasive hemo- 
dynamic assessment i  these patients was limited by 
incompressible v ssels and amputations precluding 
toe pressures, yet two patients had monophasic 
Doppler foot signals in bypasses to tibial vessels, and 
the patient with the bypass to the isolated popliteal 
segment had no change in the ABI (0.63 before 
operation; 0.63 after operation). Six of the eight pa- 
tients tmderwent postoperative graft surveillance du- 
plex scanning, with all showing normal systolic ve- 
locities with a range of 59 to 90 cm/sec and no areas 
ofstenosis. Overal113 (59%) of  22 arnputations per- 
formed after revascularization were in patients with 
functioning bypass grafts. All amputations beyond 9
months of revascularization were due to graft failure. 
The cumulative limb salvage rate was 91% at 1 
month and decreased to 57% by 2 years (Table IV). 
Limb salvage rates in patients with diabetes were 
similar, 88% at i month and 57% at 2 years. 
Fourteen of the 69 grafts falled during a mean 
follow-up interval of 13 months (range 8 days to 72 
months). Calculation of primary graft patency rates 
by life-table methods howed a cumulative patency 
rate of 96% at 1 month, 72% at 1 year, and 63% at 
2 years (Table V). Graft thrombosis resulted in six 
immediate above-knee (n = 1) or below-lmee 
(n = 5) amputätions. Two patients underwent graft 
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Table V. Cumulative primary patency of all grafts 
Interval No. of grafls Interval patency Cumulative patency 
(mo.) at risk No. failed No. withdrawn rate (%) SE (%) 
0-1 69 2 14 .96 100 0 
1-3 53 4 10 .91 96 2.6 
3-6 39 4 7 .89 88 4.8 
6-12 28 2 8 .92 78 6.9 
12-18 18 1 2 .94 72 9.0 
18-24 15 1 4 .92 68 9.9 
2440 10 0 1 1.00 63 12.1 
Table VI. Clinical failure after revascularization in 53 ESRD patients (69 procedures) 
Failure of foot salvage 
Clinical failure rate 
Postoperative time Perioperative death Graft thrombosis Foot amputation « (%) 
1 month 7 2 5 20 
1 year 7 8 13 41-~ 
«Foot lost with patent bypass graft. 
tMinimum failure rate because not all patients were monitored for 1 year (two patients lost o follow-up, seven patients monitored less 
than 1 year). 
revision or a redo bypass, and four patients had 
adequate foot perfusion without ulceration or rest 
pain after graft failure. 
Because the goal of revascularization in the 53 
patients with ESRD was limb salvage and improved 
foot perfusion, operative death, graft thrombosis, 
and foot amputation were considered proeedure 
failures. After 1 month, 14 (20%) of the 69 bypass 
grafting procedures failed to help the patient (Table 
VI). Although not all patients were monitored for 1 
year, the calculated minimum clinical failure rate in 
the 53 patients with ESRD was 41% after this time 
interval. Failure of foot salvage was the most 
common adverse outcome. Only two of seven 
patients admitted with forefoot gangrene (gangrene 
extending beyond the web space of the toes) experi- 
enced clinical success beyond 5 weeks after revascu- 
larization. Two patients died, and three patients 
required early foot amputation. When the indication 
for limb revascularization was gangrene or gangrene 
complicated by infection, the foot salvage rate was 
51% at i year versus 74% when patients were 
admitted with ischemic rest pain or nonhealing ulcers 
(p = 0.13). Ten patients with functioning kidney 
transplants underwent 13 bypasses without an op- 
erative death or early graft failure. Despite apparently 
successful bypass revascularization, four limbs re- 
quired above- (n = 2) or below-knee (n = 2) am- 
putation because of persistent ischemia. 
DISCUSSION 
Prior reports dealing wi~ lower limb bypass 
grafting in patients with ESRD have emphasized an 
increased operative morbidity rate, hut because of 
limb salvage rates in the range of 76% to 91% at 2 
years, an aggressive approach toward revasculariza- 
tion has been advocated. 2-4 Most authors have 
acknowledged the limited the life-span of these 
patients and observed limb loss despite apparently 
succëssful bypass grafting. In our patients, 13 (59%) 
of 22 amputations were performed in limbs with 
patent, functioning bypass grafts. These results ug- 
gest that surgeons need bet-ter parameters to predict 
healing of ischemic foot lesions in the patient with 
ESRD. Our review found that failure of foot salvage 
was more common in patients diagnosed with 
gangrene, particularly if the ischemic tissue was also 
involved by infection. The limb salvage rate deereased 
to 51% at 1 year when gangrene was the indication 
for surgery. Early clinical failure (operative death, 
graft failure, amputation) after revascularization in- 
creased from 20% for the overall series to 71% for the 
seven patients admitted with forefoot gangrene. 
These observations suggest hat earlier referral of 
patients with ESRD before development of major 
tissue loss could favorably influence outcome. 
It appears that healing of ischemic lesions and 
amputation sites (i.e., tissue healing) rather than graft 
failure is the obstacle in achieving foot salvage. Our 
JOURNAL OF VASCULAR SURGERY 
284 Johnson et al. September 1995 
retrospective r view cannot reliably identify patients 
in whom primary amputation would be the "best" 
treatment, but this alternative should be considered 
when extensive forefoot gangrene or infection is 
present. We found that early limb loss ( < 2 months) 
was not due to graft thrombosis but to progressive 
gangrene, absence of wound healing, and infection. 
Of the 11 amputations in the first 2 months, 10 
(91%) were in patients with patent bypasses with 
persistent foot ischemia or uncontrolled infection. 
Beyond 2 months from revascularization, eight 
(73%) of 11 amputations were the result of bypass 
failure. If the problem of limb loss despite a patent 
bypass could have been avoided, the fimb salvage rate 
in our patients would have improved from 65% to 
85% at 1 year. Therefore achieving higher early limb 
savage rates depends on bet-ter selection of patients 
for revascularization or improvements in wound 
healing and control ofinfection after surgery. Criteria 
for primary amputation i patients with ESRD and 
critical ischemia were suggested by Edwards et al.,1 
who found that the size (> 2 cm) of foot ulcers in 
patients with diabetes could predict failure of limb 
salvage. Subsequent studies have failed to confirm 
this, and in out study only three of 13 patients with 
a patent bypass when undergoing amputation had a 
nonhealing ulcer as the initial indication for surgery. 
Wassermann et al.,s in a study of 42 bypasses in 
paticnts with ESRD, believed that a preoperative 
ABI <0.3 was predictive of poor limb salvage. 
Larger studies of patients undergoing infrainguinal 
bypass have failed to find preoperative ABIs statisti- 
cally significant for predicting limb salvage. 8 
Out review highlights the problem of clinical 
failure despite successful bypass grafting that oc- 
curred in 13 patients in out series. Multiple studies 
have reported this problem, especially in patients 
with diabetes, large ischemic ulcers, and bypasses to 
isolated popliteal segments) ,<6,7,9 Orte reason for the 
failure of bypass grafting to prevent foot loss in 
patients with ESRD could be due to the incorrect 
placement of the distal anastomosis. In our study, 
seven of eight limbs with a patent bypass requiring 
amputation because of tissue ischemia had the distal 
anastomosis performed to a tibial or pedal artery. 
This should have provided adequate perfusion to 
prcvent progression of gangrene or to achieve ulcer 
healing. The angiographic reports howed that three 
of these patients had an incomplete foot arch. One 
patient had a bypass to an isolated popliteal artery. 
Postoperative noninvasive hemodynamic assessment 
in these patients was limited by incompressible 
vessels, amputations precluding toe pressures and 
nonavailability of laser Doppler velocimeter and 
transcutaneous oximetry. When these data were 
available it showed monophasic Doppler foot signals 
in bypasses to tibial vessels in two patients and no 
improvement in the ABI of the patient with the 
bypass to the isolated popliteal segment. The in- 
creased percentage of limbs amputated with a patent 
bypass in patients with ESRD suggests that, al- 
though successful revascularization a d foot salvage 
require operative technical precision, they also de- 
pend greatly on careful preoperative selection of 
operative candidates, with detailed angiographic 
assessment of foot vessels and consideration for 
primary amputation i  those patients with only an 
isolated popliteal artery. 
Even with adequate perfusion, failure of tissue 
healing in patients with ESRD could be explained by 
associated conditions uch as anemia, malnutrition, 
and depressed immune function. Delayed wound 
healing occurs with uremia, which reduces formation 
ofgranulation tissue in wounds when compared with 
controls. 1° In addition, diabetes, adisease present in 
most patients with ESRD, is also associated with a 
deficiency of coUagen content in granulation tissue. 
Although patients undergoing transplantation are 
not affected by uremia, they receive immunosuppres- 
sive medications that impair wound healing. It has 
been suggested that use of nonnephrotoxic antibiot- 
ics such as cefoperazone in patients with lddney 
transplants can reduce wound infection rates and 
thereby improve wound healing, n The use ofrecom- 
binant human tissue growth factor may be needed in 
patients with ESRD to promote tissue regeneration 
and healing. This hormone has been shown to 
enhance protein balance and increase wound healing 
and immune function in the malnourished patient 
undergoing hemodialysis. 12 
Problems of impaired healing and resistance to 
infection orten result in wound complications in 
patients with ESRD after they undergo lower limb 
bypass grafting. In this series, 20 (29%) procedures 
were associated with wound complications, ofwhich 
eight required a return to the operating room for 
treatment. We used an in situ bypass technique in 
52% of the procedures, which may have contributed 
to the high number of wound problems. Of note, 
both grafts that required ligation because of a wound 
complication were in situ saphenous vein bypasses. 
Wassermann et al.s reported a 36% incidence of 
wound complications with only reversed saphenous 
vein grafting but did not have any wound problems 
that resulted in graft ligation or rupture. These 
authors believed that tunneling the vein graft in an 
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anatomic or subfascial plane was an important 
technical maneuver when operating on patients with 
ESRD.  
It is important when considering any major 
operation to be cognizant of  its overall outcome and 
benefit to the patient. Perioperative death, graft 
thrombosis,  and amputations with patent grafts 
obviously do not benefit he patient with ESRD and 
critical ischemia. We found the clinical failure rate to 
be 22% at 1 month  and 41% at 1 year. These 
sobering results occurred despite a high technical 
success rate with bypäss grafting (30-day primary 
graft patency rate of  96%). I f the  most  frequent cause 
o f  failure, amputat ion with a patent graft, could be 
eliminated, the outcome of  surgical revascularization 
could be improved significantly. We continue to 
recommend infrainguinal bypass grafting to patients 
with ESRD when a multidisciplinary evaluation 
indicates that l imb salvage is likely. In patients with 
gangrene and infection, consultation with plastic 
surgery and infectious disease are frequently ob- 
tained. Although we were not able to identify 
conclusively which factors will predict l imb loss, we 
believe that referral at the first signs o f  foot ischemia 
and consideration for pr imary amputat ion in patients 
with forefoot gangrene or poor  runoff  (documented 
by angiographic assessment with complete foot films) 
should decrease the failures of  foot salvage seen 
within the first 2 months after infrainguinal bypass 
graf ring. 
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DISCUSSION 
Dr. Frank J. Veith (Bronx, N.Y.) I generally agree 
with the findings and condusions of this study. My 
agreement is based on a recent 10-year analysis that Dr. 
Luis Sanchez 7 carried out on 141 threatened limbs in 112 
patients with ESRD. When gangrene and infection were 
extensive and involved the mid foot, as was the case in 21 
limbs, we performed a primary amputation. We attempted 
limb salvage by balloon angioplasty in 40 limbs and by 
bypass in the remaining 80 limbs. Our overall 30-day and 
late mortality rates were almost identical to Dr. Johnson's. 
Our results with bypasses were much better than those with 
balloon angioplasty, eren though the bypasses were 
perforrned in the rnore difficult situations with worse 
arterial disease. The 6-month limb salvage rates were 
83% +- 5% with bypasses and only 50% _+ 11% with 
percutaneous transluminal angioplasty (PTA). Moreover, 
PTA of-ten (seven limbs) delayed the rescue bypass o that, 
eren when the bypass was successful, the limb was lost. We 
therefore believe PTA to be a poor option for treating 
limb-threatening ischemia in patients with ESRD. Like Dr. 
Johnson, we had a high incidence in these patients of limb 
loss despite a patent bypass and a pälpable foot pulse. This 
always occurred in the face of extensive infection or 
gangrene as he found, and it is in this group of patients with 
ESRD that we believe primary amputation to be 
appropriate; however, if necrosis is limited, bypasses are 
worthwhile eren in patients with diabetes and ESRD. 
Some good results can be obtained in this setting. Surgeons 
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undertaking these procedures must, however, be aware that 
these patients with ESRD and diabetes have calcified, 
difficult arteries to deal with and high operative mortality 
and morbidity rates. 
What are your views on the role of PTA in patients with 
ESRD? How precisely do you determine when forefoot 
infection and gangrene are extensive nough to justify 
primary amputation? 
Dr. Brad L. Johnson. We have not used PTA in our 
patients very often and, given the severity of disease in this 
patient population, I do not believe that it would meet with 
rauch success, especially given the degree of gangrene seen 
in these patients. 
We also have difficulty trying to choose those patients 
who should proceed to undergo primary amputation with 
forefoot gangrene, hut given that only two ofseven patients 
experienced clinical success, we believe that probably this 
group of patients should proceed directly to primary 
amputation. 
Dr. James Seeger (Gainesville, Fla.). You stated that 
you performed some amputations eren with patent bypass 
grafts presumably because you couldn't control the infec- 
tion in the foot. What information do you have that 
documents good perfusion to the foot, even out into the 
toes in these patients! Did you have toe pressures that 
confirm the hemodynamics of the foot? Alternatively, do 
you have any information about he arterial anatomy in the 
foot, not whether there were patent pedal arches but rather 
whether digital arteries were present so that there was a 
potential of getting perfusion out to the area that was 
infected? 
Dr. Johnson. Yes, we were concerned about whether 
we had adequate distal perfusion. No, we have not 
reviewed angiograms to assess patent arches or digital 
arteries. 
Dr. William Suggs (Bronx, N.Y.). I have believed that 
the flow should be adequate for wound healing because of 
pulsatile flow coming from small digital calcified vessels, 
and yet in 2 däys after what appears to be a clean wound, 
the muscle turns gray and the foot is unsalvageable. Has 
that been your experience, that eren when the wound looks 
clean and the amputation looks adequate, 2 or 3 days later 
there is a local wound healing problem that then leads to 
a below-knee amputation? 
Dr. Johnson. We had patients in whom we believed 
we had successful limb salvage with good perfusion hut 
who continued to progress with gangrene. We had one 
patient who had an ulcer that eventually eroded into bis 
ankle joint, which led to limb loss, so, yes, it still occurs 
when you believe you have adequate perfusion to the distal 
foot. 
Dr. Timothy R. S. Harward (Gainesville, Fla.). I 
want to answer the question pertaining to small-vessel 
disease in the patient with diabetes. Dr. Strandness, ämong 
others, has shown quite nicely that small-vessel disease does 
not occur in the feet of patients with diabetes. In patients 
with diabetes and ESRD, tibial arteries are noncompress- 
ible because of medial calcinosis hut orte can still compress 
the digital artery. With a photoplethysmograph nda small 
cuff, orte can very accurately measure toe pressures in the 
second, third, or fourth toes, whereas ifyou move up to the 
an!de or transmetatarsal areas, you are measuring pressure 
in the dorsalis pedis arteries, which are calcified; therefore 
you can't compress the artery. 
